Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIFAMPIN Cause Wrong technique in product usage process? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Wrong technique in product usage process have been filed in association with RIFAMPIN (Rifampin). This represents 0.1% of all adverse event reports for RIFAMPIN.

19
Reports of Wrong technique in product usage process with RIFAMPIN
0.1%
of all RIFAMPIN reports
0
Deaths
6
Hospitalizations

How Dangerous Is Wrong technique in product usage process From RIFAMPIN?

Of the 19 reports, 6 (31.6%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does RIFAMPIN Cause?

Drug ineffective (1,238) Drug reaction with eosinophilia and systemic symptoms (1,049) Drug interaction (735) Pyrexia (735) Acute kidney injury (684) Drug-induced liver injury (684) Off label use (640) Condition aggravated (597) Nausea (572) Paradoxical drug reaction (570)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which RIFAMPIN Alternatives Have Lower Wrong technique in product usage process Risk?

RIFAMPIN vs RIFAMYCIN RIFAMPIN vs RIFAPENTINE RIFAMPIN vs RIFAXIMIN RIFAMPIN vs RILMENIDINE RIFAMPIN vs RILONACEPT

Related Pages

RIFAMPIN Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process RIFAMPIN Demographics